Publications - 'P'
Publications 576 - 600 de 2458
| Titre | DOI |
|---|---|
|
PERTURBATION MATRICES AND THEIR SINGULAR VALUES J. Sjostrand 2014 |
|
|
PERTURBATION THEORY FOR INDEFINITE POTENTIALS M. Mokhtar-Kharroubi 2016 |
|
|
Perturbation vectors to evaluate air quality using lichens and bromeliads: a Brazilian case study F. Monna; ; R. Guillon; R. Losno; S. Couette; N. Navarro; G. Dongarra; E. Tamburo; D. Varrica; C. Chateau; F.O. Nepomuceno 2017 |
10.1007/s10661-017-6280-0 |
|
Pertussis: Where do we stand 10 years after the introduction of cocooning vaccination strategy in France? E. Beaufils; M.A. Dommergues; J. Gaillat; N. Guiso; N. Knezovic-Daniel; D. Pinquier; D. Riethmuller 2016 |
10.1016/j.gyobfe.2016.08.003 |
|
Pertuzumab and T-DM1: New perspectives in the treatment of HER2-positive breast cancer S. Guiu; P. Fumoleau 2015 |
10.1007/s10269-015-2484-5 |
|
Pessimism of the intellect, optimism of the imagination: Calvino and the speculative fiction seen from the perspective of Leopardi and his interpreters R. Maggiore 2019 |
10.4000/laboratoireitalien.3870 |
|
Pest management under climate change: The importance of understanding tritrophic relations V. Castex; M. Beniston; P. Calanca; D. Fleury; J. Moreau 2018 |
10.1016/j.scitotenv.2017.11.027 |
|
Pesticide fate modeling in soils with the crop model STICS: Feasibility for assessment of agricultural practices W. Queyrel; F. Habets; H. Blanchoud; D. Ripoche; M. Launay 2016 |
10.1016/j.scitotenv.2015.10.066 |
|
Pesticide-free agriculture as a new paradigm for research F. Jacquet; M.H. Jeuffroy; J. Jouan; E. Le Cadre; I. Litrico; T. Malausa; X. Reboud; C. Huyghe 2022 |
10.1007/s13593-021-00742-8 |
|
Pesticides threaten an endemic raptor in an overseas French territory M. Coeurdassier; A. Villers; S. Augiron; M. Sage; F.X. Couzi; V. Lattard; I. Fourel 2019 |
10.1016/j.biocon.2019.03.022 |
|
PET imaging of neurotensin receptor-positive tumors with Ga-68-labeled antagonists: ``the chelate makes again the difference'' E. Renard; F. Denat; V. Goncalves; M. Moreau; P.S. Bellaye 2021 |
|
|
PET imaging of neurotensin receptor-positive tumors with Ga-68-labeled antagonists: ``the chelate makes again the difference'' E. Renard; F. Denat; V. Goncalves; M. Moreau; P.S. Bellaye 2021 |
|
|
PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study R.O. Casasnovas; R. Bouabdallah; P. Brice; J. Lazarovici; H. Ghesquieres; A. Stamatoullas; J. Dupuis; A.C. Gac; T. Gastinne; B. Joly; K. Bouabdallah; E. Nicolas-Virelizier; P. Feugier; F. Morschhauser; R. Delarue; H. Farhat; P. Quittet; A. Berriolo-Riedinger; A. Ternpescul; V. Edeline; N. Maisonneuve; L.M. Fomecker; T. Lamy; A. Delmer; P. Dartigues; L. Martin; M. Andre; N. Moonier; A. Traverse-Glehen; M. Meignan 2019 |
10.1016/S1470-2045(18)30784-8 |
|
PET-based prognostic survival model after radiotherapy for head and neck cancer J. Castelli; A. Depeursinge; A. Devillers; B. Campillo-Gimenez; Y. Dicente; J.O. Prior; E. Chajon; F. Jegoux; C. Sire; O. Acosta; E. Gherga; X. Sun; B. De Bari; J. Bourhis; R. de Crevoisier 2019 |
10.1007/s00259-018-4134-9 |
|
PET-guided, BEACOPP(escalated) therapy in advanced Hodgkin lymphoma reply R.O. Casasnovas; R. Bouabdallah; P. Brice; J. Lazarovici; H. Ghesquieres; A. Stamatoullas; A. Berriolo-Riedinger; L.M. Fornecker; M. Andre; M. Meignan 2019 |
10.1016/S1470-2045(19)30156-1 |
|
PET-MRI imaging of neurotensin receptor-positive tumors with Ga-68-labeled antagonists : ``the chelate makes again the difference'' V. Goncalves; E. Renard; M. Moreau; P.S. Bellaye; M. Guillemin; F. Denat 2020 |
|
|
PET-MRI imaging of neurotensin receptor-positive tumors with Ga-68-labeled antagonists : ``the chelate makes again the difference'' V. Goncalves; E. Renard; M. Moreau; P.S. Bellaye; M. Guillemin; F. Denat 2020 |
|
|
PET/MR, the optimal imaging tool for quantitative biodistribution studies in nanoparticle research A. Courteau; M. Moreau; P.M. Walker; M. Guillemin; C. Drouet; A. Oudot; L. Carchon; S. Roux; J. McGrath; R. Garipov; A. Cochet; F. Brunotte; J.M. Vrigneaud 2019 |
|
|
PET/MR, the optimal imaging tool for quantitative biodistribution studies in nanoparticle research A. Courteau; M. Moreau; P.M. Walker; M. Guillemin; C. Drouet; A. Oudot; L. Carchon; S. Roux; J. McGrath; R. Garipov; A. Cochet; F. Brunotte; J.M. Vrigneaud 2019 |
|
|
Petersen Graph Multi-Orientation Based Multi-Scale Ternary Pattern (PGMO-MSTP): An Efficient Descriptor for Texture and Material Recognition I.El Khadiri; Y.El Merabet; A.S. Tarawneh; Y. Ruichek; D. Chetverikov; R. Touahni; A.B. Hassanat 2021 |
10.1109/TIP.2021.3070188 |
|
Pezizomycetes genomes reveal the molecular basis of ectomycorrhizal truffle lifestyle C. Murat; T. Payen; B. Noel; A. Kuo; E. Morin; J. Chen; A. Kohler; K. Krizsan; R. Balestrini; C. Da Silva; B. Montanini; M. Hainaut; E. Levati; K.W. Barry; B. Belfiori; N. Cichocki; A. Clum; R.B. Dockter; L. Fauchery; J. Guy; M. Iotti; F. Le Tacon; E.A. Lindquist; A. Lipzen; F. Malagnac; A. Mello; V. Molinier; S. Miyauchi; J. Poulain; C. Riccioni; A. Rubini; Y. Sitrit; R. Splivallo; S. Traeger; M. Wang; L. Zifcakova; D. Wipf; A. Zambonelli; F. Paolocci; M. Nowrousian; S. Ottonello; P. Baldrian; J.W. Spatafora; B. Henrissat; L.G. Nagy; J.M. Aury; P. Wincker; ; P. Bonfante; F.M. Martin 2018 |
10.1038/s41559-018-0710-4 |
|
PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia C. Vayne; J. Rollin; Y. Gruel; C. Pouplard; H. Galinat; O. Huet; V. Memier; T. Geeraerts; R. Marlu; G. Pernod; G. Mourey; A. Fournel; C. Cordonnier; S. Susen 2021 |
10.1056/NEJMc2106383 |
|
pH-Responsive PEG/PAA Multilayer Assemblies for Reversible Adhesion of Micro-Objects C.C. Buron; T. Vrlinic; T. Le Gallou; S. Lakard; A. Bolopion; P. Rougeot; B. Lakard 2020 |
10.1021/acsapm.0c00942 |
|
PHACE syndrome, a series of six patients: clinical and morphological manifestations, propranolol efficacy, and safety G. Bellaud; E. Puzenat; N.Celia Billon-Grand; P. Humbert; F. Aubin 2015 |
10.1111/ijd.12489 |
|
Phakomatosis pigmentovascularis is caused by somatic missense mutations in GNA11: a new addition to the mosaic G protein disorder group A. Thomas; Z. Zeng; R. O'Shaughnessy; J.B. Riviere; R. Waelchli; L. Al-Olabi; S. Loughlin; M. Glover; I. Khan; M. Lapidot; E. Sprecher; M. Wobser; H. Hamm; P. Vabres; E. Patton 2015 |